Activity of Drug Combinations against Dormant Mycobacterium tuberculosis
- 1 June 2010
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 54 (6) , 2712-2715
Abstract
Aerobic (5-day-old cultures) and nonreplicating (dormant) Mycobacterium tuberculosis (5-, 12-, and 19-day-old cultures) bacteria were treated with rifampin (R), moxifloxacin (MX), metronidazole (MZ), amikacin (AK), or capreomycin (CP) for 7, 14, and 21 days. R-MX-MZ-AK and R-MX-MZ-CP killed both aerobic and dormant bacilli in 21 days, as shown by lack of regrowth in solid and liquid media. R-MX-MZ-AK and R-MX-MZ-CP also caused a strong decrease of nonreplicating bacilli in 7 days in a cell-based dormancy model.Keywords
This publication has 13 references indexed in Scilit:
- The spectrum of latent tuberculosis: rethinking the biology and intervention strategiesNature Reviews Microbiology, 2009
- Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosisNature Reviews Microbiology, 2008
- A Common Mechanism of Cellular Death Induced by Bactericidal AntibioticsCell, 2007
- Metronidazole plus Rifampin Sterilizes Long-Term Dormant Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2007
- Low-Oxygen-Recovery Assay for High-Throughput Screening of Compounds against Nonreplicating Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2007
- Is Adipose Tissue a Place for Mycobacterium tuberculosis Persistence?PLOS ONE, 2006
- In Vitro Model of Hypoxically Induced Nonreplicating Persistence of Mycobacterium tuberculosis2001
- Protein synthesis is shutdown in dormantMycobacterium tuberculosisand is reversed by oxygen or heat shockFEMS Microbiology Letters, 1998
- Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 1994
- Nitroimidazole drugs-action and resistance mechanisms I. Mechanism of actionJournal of Antimicrobial Chemotherapy, 1993